Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Return on Equity (2020 - 2023)

Historic Return on Equity for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to 0.32%.

  • Therapeutics' Return on Equity rose 3100.0% to 0.32% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.32%, marking a year-over-year increase of 3100.0%. This contributed to the annual value of 0.65% for FY2023, which is 2500.0% down from last year.
  • Latest data reveals that Therapeutics reported Return on Equity of 0.32% as of Q3 2024, which was up 3100.0% from 0.56% recorded in Q2 2024.
  • In the past 5 years, Therapeutics' Return on Equity ranged from a high of 0.31% in Q3 2021 and a low of 0.79% during Q4 2023
  • Moreover, its 5-year median value for Return on Equity was 0.41% (2022), whereas its average is 0.48%.
  • Its Return on Equity has fluctuated over the past 5 years, first crashed by -4000bps in 2023, then surged by 3100bps in 2024.
  • Therapeutics' Return on Equity (Quarter) stood at 0.49% in 2020, then increased by 28bps to 0.36% in 2021, then fell by -11bps to 0.39% in 2022, then crashed by -101bps to 0.79% in 2023, then surged by 59bps to 0.32% in 2024.
  • Its Return on Equity was 0.32% in Q3 2024, compared to 0.56% in Q2 2024 and 0.69% in Q1 2024.